Thrombostatin In The Folts Model for Coronary Thrombosis
Thrombostatin In The Folts Model for Coronary Thrombosis
批准号:
6338041
负责人:
ALVIN H SCHMAIER
金额:
$58.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-15 至 2004-03-31
关键词:
Fungi antithrombins biotechnology calcium flux calcium indicator cardiovascular disorder chemotherapy chemical structure function coronary occlusion /thrombosis disease /disorder model dogs drug design /synthesis /production fluorescence spectrometry human subject intermolecular interaction nonhuman therapy evaluation peptide chemical synthesis pharmacokinetics platelet activation thrombin receptor
中文摘要
描述(申请人的逐字描述):本提案的假设
是一种选择性干扰血小板的凝血酶抑制物
激活将是治疗急性脑出血的重要治疗手段
冠脉综合征。Thromgen,Inc.正在开发一种称为
血栓抑素作为抗凝血酶、抗血小板药物用于心脏
攻击和介入性心血管手术。凝血酶抑制素预防
A-凝血酶激活血小板。它是一种双功能抑制剂,
与凝血酶S活性部位的相互作用弱,与凝血酶的相互作用更紧密
凝血酶受体,蛋白酶激活受体1(PAR 1)。凝血酶抑素是一种
新型血小板选择性凝血酶抑制剂。这项建议的具体目的
详情如下:
具体目标1:将进行研究,以制备更有效和更有选择性的
经验法合成凝血酶活性抑制物PAR1及其合理应用
药物设计。
特定目标2:血栓抑素和血小板的抗血栓形成能力
糖蛋白IIb/IIIa拮抗剂将在狗身上进行比较。
这些研究将导致开发出一类新的
用于预防动脉血栓形成的血小板选择性凝血酶抑制剂。这些
调查还将导致一种新的治疗方法来管理
急性冠脉综合征的患者。
建议的商业应用:
不可用
英文摘要
DESCRIPTION (Applicant's Description Verbatim): The hypothesis of this proposal
is that a thrombin inhibitor that selectively interferes with platelet
activation will be an important therapeutic agent in the management of acute
coronary syndromes. Thromgen, Inc. is developing a class of agents called
thrombostatin as antithrombin, anti-platelet drugs to be used for heart
attacks and interventional cardiovascular procedures. Thrombostatin prevents
a-thrombin from activating platelets. It is a bifunctional inhibitor that
weakly interacts with thrombin' s active site and more tightly interacts with
thrombin's receptor, protease-activated receptor 1 (PAR 1). Thrombostatin is a
novel platelet-selective thrombin inhibitor. The specific aims of this proposal
are as follows:
Specific Aim #1: Studies will be done to prepare more potent and selective
inhibitors of thrombin activation of PAR1 by empiric synthesis and rational
drug design.
Specific Aim #2: The antithrombotic ability of thrombostatin and platelet
glycoprotein IIb/IIIa antagonists will be compared in dogs.
These investigations will result in the development of a novel class of
platelet-selective thrombin inhibitors to prevent arterial thrombosis. These
investigations also will result in a new therapeutic approach to the management
of patients with acute coronary syndromes.
PROPOSED COMMERCIAL APPLICATION:
Not Available
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tyrosine Kinases and Thrombosis
-
批准号:10367450
-
项目类别:
-
资助金额:$54.01万
-
财政年份:2022
-
负责人:ALVIN H SCHMAIER
-
依托单位:
Tyrosine Kinases and Thrombosis
-
批准号:10573189
-
项目类别:
-
资助金额:$46.78万
-
财政年份:2022
-
负责人:ALVIN H SCHMAIER
-
依托单位:
KININ2018CLE
-
批准号:9471651
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2018
-
负责人:ALVIN H SCHMAIER
-
依托单位:
Prolylcarboxypeptidase is a Risk Factor for Cardiovascular Disease
-
批准号:8262208
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2012
-
负责人:ALVIN H SCHMAIER
-
依托单位:
Prolylcarboxypeptidase is a Risk Factor for Cardiovascular Disease
-
批准号:8448685
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2012
-
负责人:ALVIN H SCHMAIER
-
依托单位:
CORE--MOUSE COAGULALTION LABORATORY
-
批准号:6504161
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2001
-
负责人:ALVIN H SCHMAIER
-
依托单位:
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE
-
批准号:6527593
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2000
-
负责人:ALVIN H SCHMAIER
-
依托单位:
CORE--MOUSE COAGULALTION LABORATORY
-
批准号:6356277
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2000
-
负责人:ALVIN H SCHMAIER
-
依托单位:
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE
-
批准号:6656245
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2000
-
负责人:ALVIN H SCHMAIER
-
依托单位:
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE
-
批准号:6152956
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2000
-
负责人:ALVIN H SCHMAIER
-
依托单位:
PLASMA PROTEIN PHENOTYPING OF PROTHROMBOTIC MICE
-
批准号:6390790
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2000
-
负责人:ALVIN H SCHMAIER
-
依托单位:
CORE--MOUSE COAGULALTION LABORATORY
-
批准号:6202568
-
项目类别:
-
资助金额:$21.31万
-
财政年份:1999
-
负责人:ALVIN H SCHMAIER
-
依托单位:
CORE--MOUSE COAGULALTION LABORATORY
-
批准号:6110821
-
项目类别:
-
资助金额:$21.31万
-
财政年份:1998
-
负责人:ALVIN H SCHMAIER
-
依托单位:
THROMBOSTATIN--A SELECTIVE ANTITHROMBIN
-
批准号:2872942
-
项目类别:
-
资助金额:$32.26万
-
财政年份:1997
-
负责人:ALVIN H SCHMAIER
-
依托单位:
CORE--MOUSE COAGULALTION LABORATORY
-
批准号:6242815
-
项目类别:
-
资助金额:$20.56万
-
财政年份:1997
-
负责人:ALVIN H SCHMAIER
-
依托单位:
THROMBOSTATIN--A SELECTIVE ANTITHROMBIN
-
批准号:2030050
-
项目类别:
-
资助金额:$31.05万
-
财政年份:1997
-
负责人:ALVIN H SCHMAIER
-
依托单位:
THROMBOSTATIN--A SELECTIVE ANTITHROMBIN
-
批准号:2655292
-
项目类别:
-
资助金额:$31.65万
-
财政年份:1997
-
负责人:ALVIN H SCHMAIER
-
依托单位:
REGULATION OF KININ DELIVERY ON HUVEC
-
批准号:6183829
-
项目类别:
-
资助金额:$30.76万
-
财政年份:1996
-
负责人:ALVIN H SCHMAIER
-
依托单位:
Thrombostatin-A Thrombin Receptor Inhibitor
-
批准号:7072202
-
项目类别:
-
资助金额:$60.69万
-
财政年份:1996
-
负责人:ALVIN H SCHMAIER
-
依托单位:
REGULATION OF KININ DELIVERY ON HUVEC
-
批准号:6745141
-
项目类别:
-
资助金额:$32.77万
-
财政年份:1996
-
负责人:ALVIN H SCHMAIER
-
依托单位:
海外基金